Novaquest Capital Management

NovaQuest Capital Management is a prominent investment firm based in Raleigh, North Carolina, specializing in providing customized capital solutions to companies across the life sciences sector, including pharmaceutical, biotechnology, and medical device firms. Established with a deep understanding of the biopharma industry, NovaQuest differentiates itself by offering flexible financing structures tailored to the unique needs of its portfolio companies, moving beyond traditional venture capital or private equity models. The firm has demonstrated significant scale, having raised over $3.5 billion in capital across its various funds since its inception.

NovaQuest employs three primary investment strategies. Its Product Finance strategy provides non-dilutive capital, often against future product sales, targeting commercial or near-commercial stage products. This approach allows biopharma companies to access substantial funding without equity dilution. The Strategic Opportunities strategy offers flexible capital for a broader range of situations, such as mergers and acquisitions, corporate spin-outs, or late-stage product development. Lastly, its Private Equity arm focuses on growth equity and buyout investments in life sciences service and technology companies, supporting the infrastructure and innovation ecosystem of the industry.

With a robust track record, NovaQuest Capital Management has completed over 30 transactions, deploying significant capital to support the growth and strategic initiatives of its partners. For instance, in 2021, the firm closed its NovaQuest Pharma Opportunities Fund V with commitments totaling $1.2 billion, underscoring its continued capacity for large-scale investments. The firm's ability to structure complex, multi-million dollar deals, such as a reported $200 million financing agreement with Horizon Therapeutics, highlights its capability to provide substantial financial backing, making it a key player for established and rapidly growing life sciences enterprises seeking bespoke capital solutions.